Skip to content
AdminDec 9, 2020< 1 min read

Synthetic Clinical Trial Data: Use Cases, Methods, and Experiences

2020-12-09-Synthetic-Clinical-Trial-Data-Use-Cases-Methods-and-Experiences

Stephen Bamford, Head of Clinical Data Standards & Transparency; IDAR, Global Development, Janssen

Sharing experiences with the synthesis of clinical trial data and how that data has been used by a pharmaceutical company.

 

Following the acquisition of Replica Analytics by Aetion, the generative AI technology previously known as Replica Synthesis is now Aetion® Generate and continues to create privacy-enhancing synthetic data.
Learn More

RELATED ARTICLES

Natalie Schibell, MPHNov 21, 20243 min read

Own the Future of Healthcare: Aetion’s AI/ML Tools Turn Data Into Impact

Healthcare stands at a crossroads. The pressure to deliver better care at lower costs is relentless, but the key to unlocking ...
Start Reading
AdminNov 20, 2024< 1 min read

Frameworks and Tools for Generating Decision-Grade RWE | Jan 12, 2023

Watch the webinar Frameworks and Tools for Generating Decision-Grade RWE to explore essential tools and templates to better ...
Start Reading
AdminOct 31, 20243 min read

Applying AI to RWE and Drug Development

With applications abound, AI is poised to change how RWD/RWE teams operate and how quickly they can accelerate drug ...
Start Reading